TD Asset Management Inc Lowers Holdings in Stryker Corporation $SYK

TD Asset Management Inc trimmed its position in Stryker Corporation (NYSE:SYK) by 38.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 615,132 shares of the medical technology company’s stock after selling 380,023 shares during the period. TD Asset Management Inc’s holdings in Stryker were worth $216,200,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Godfrey Financial Associates Inc. purchased a new position in Stryker in the 4th quarter valued at $26,000. United Financial Planning Group LLC purchased a new position in Stryker in the 3rd quarter valued at $27,000. Strive Asset Management LLC purchased a new position in Stryker in the 3rd quarter valued at $30,000. CGC Financial Services LLC purchased a new position in Stryker in the 4th quarter valued at $29,000. Finally, ANTIPODES PARTNERS Ltd purchased a new position in Stryker in the 3rd quarter valued at $34,000. 77.09% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Stryker

In other news, Director Ronda E. Stryker sold 310,000 shares of Stryker stock in a transaction on Tuesday, May 26th. The stock was sold at an average price of $312.23, for a total transaction of $96,791,300.00. Following the completion of the transaction, the director owned 1,924,880 shares of the company’s stock, valued at $601,005,282.40. The trade was a 13.87% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, VP M Kathryn Fink sold 5,220 shares of Stryker stock in a transaction on Monday, May 11th. The stock was sold at an average price of $283.85, for a total value of $1,481,697.00. Following the transaction, the vice president directly owned 13,137 shares of the company’s stock, valued at $3,728,937.45. This trade represents a 28.44% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 323,264 shares of company stock valued at $100,659,489 in the last 90 days. 4.60% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on SYK shares. Needham & Company LLC decreased their target price on shares of Stryker from $454.00 to $418.00 and set a “buy” rating on the stock in a research report on Friday, May 1st. Jefferies Financial Group restated a “buy” rating and set a $465.00 target price on shares of Stryker in a research report on Wednesday, March 4th. Robert W. Baird set a $385.00 target price on shares of Stryker in a research report on Friday, May 1st. Leerink Partners started coverage on shares of Stryker in a research report on Monday, April 13th. They set an “outperform” rating and a $410.00 target price on the stock. Finally, Truist Financial restated a “hold” rating and set a $330.00 target price (down from $380.00) on shares of Stryker in a research report on Monday, May 4th. Sixteen research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $395.48.

Stryker Trading Up 0.8%

NYSE:SYK opened at $295.63 on Thursday. The company has a market capitalization of $113.33 billion, a PE ratio of 34.22, a price-to-earnings-growth ratio of 1.85 and a beta of 0.78. The company has a quick ratio of 1.25, a current ratio of 2.11 and a debt-to-equity ratio of 0.62. Stryker Corporation has a 52-week low of $281.00 and a 52-week high of $404.87. The stock has a fifty day simple moving average of $319.41 and a 200-day simple moving average of $346.58.

Stryker (NYSE:SYK) last released its quarterly earnings results on Thursday, April 30th. The medical technology company reported $2.60 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.98 by ($0.38). The firm had revenue of $6.02 billion for the quarter, compared to analyst estimates of $6.34 billion. Stryker had a return on equity of 23.42% and a net margin of 13.20%.The company’s quarterly revenue was up 2.6% compared to the same quarter last year. During the same period last year, the firm earned $2.84 EPS. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. On average, equities research analysts expect that Stryker Corporation will post 14.98 earnings per share for the current fiscal year.

Stryker Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Tuesday, June 30th will be paid a dividend of $0.88 per share. This represents a $3.52 annualized dividend and a dividend yield of 1.2%. The ex-dividend date of this dividend is Tuesday, June 30th. Stryker’s payout ratio is 40.74%.

Stryker Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.